Key result
Women with breast cancer show similar 10-year cardiovascular risk compared to women without cancer.
Why the study?
Aging breast cancer survivors may face elevated CVD risk, but little is known regarding CVD risk assessment and breast cancer in Korean women.
Does breast cancer survivorship increase the 10-year Framingham Risk Score for cardiovascular disease in Korean women?
Cross-Sectional (n=680)
Does breast cancer survivorship increase the 10-year Framingham Risk Score for cardiovascular disease in Korean women?
Absolute Event Rate: 4.92% vs 5.47%
p-value: p=0.153
In a Korean national survey, breast cancer survivors did not have a higher 10-year predicted cardiovascular risk by Framingham Risk Score compared to matched women without cancer.
Similar FRS does not support heightened CVD screening by history alone in Korean women; leaves open longitudinal validation against actual events.
Background Aging breast cancer survivors may be at an elevated risk of cardiovascular disease (CVD), but little is known about CVD risk assessment and breast cancer in Korean women. We hypothesized that Korean breast cancer survivors would have higher risks of future CVD within the next 10 years (i.e., Framingham Risk Score [FRS]) than women without cancer. Objectives (1) To compare FRS-based CVD risks in women with and without breast cancer based on propensity score matching; and (2) To explore adiposity-related measures in relation to FRS in Korean women with breast cancer. Methods Using the cross-sectional data from the 2014–2018 Korean National Health and National Survey (KNHANES), we identified 136 women with breast cancer aged 30–74 years who had no other cancer and no CVD. The comparison group of 544 women with no cancer were selected by 1:4 nearest-neighbor propensity score matching based on breast cancer diagnosis. CVD risk was assessed by FRS based on multiple traditional risk factors (e.g., cholesterol, blood pressure, diabetes, and smoking). Adiposity was measured by physical examination, including body mass index (BMI) and waist-to-height ratio (WHtR). Physical activity and health behaviors were assessed by self-reports. Results Women with breast cancer (mean age of 57 years) had similar FRS levels at a low-risk category (< 10%) to women with no cancer (4.9% vs. 5.5%). Breast cancer survivors (mean 8.5 survival years) presented at significantly lower levels of total cholesterol, BMI, and WHtR (all p values < 0.05) than their counterpart. Within the breast cancer group, WHtR ≥ 0.5 was associated with higher FRS, compared to WHtR < 0.5. FRS was not different by survival < 5 years or ≥ 5 years after breast cancer diagnosis. Conclusions FRS-based CVD risks were not different in Korean, mostly postmenopausal, women by breast cancer status. Whereas breast cancer survivors had even lower levels of lipid and adiposity measures than women without cancer, those values indicating borderline cardiometabolic risk suggest continued screening and management efforts for these aging women. Future studies are needed to examine longitudinal trajectories of CVD risk factors and CVD outcomes among Korean breast cancer survivors.
No takes yet. Share an insight, caveat, or question.
Choi et al. (2023) conducted a cross-sectional in Breast cancer (n=680). Breast cancer vs. No cancer was evaluated on Framingham Risk Score (FRS) percentage (p=0.153). Women with breast cancer had a similar 10-year cardiovascular disease risk compared to women without cancer, with mean Framingham Risk Scores of 4.92% and 5.47%, respectively.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: